SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Assessment of semi-automated nucleic acid testing programme in a Regional Blood Transfusion Centre
14 references·0 citing·29 second hop
Assessment of semi-automated nucleic acid testing programme in a Regional Blood Transfusion Centre (2016)Assessment of semi-automated nucleic acid…Voluntary blood donation in India: Achievements, expectations and challenges (2015)Voluntary blood donation in I…Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety (2015)Individual donor-nucleic acid…Automated nucleic acid amplification testing in blood banks: An additional layer of blood safety (2015)Automated nucleic acid amplif…Half a decade of mini-pool nucleic acid testing: Cost-effective way for improving blood safety in India (2014)Half a decade of mini-pool nu…Factors in enhancing blood safety by nucleic acid technology testing for human immunodeficiency virus, hepatitis C virus and hepatitis B virus (2014)Factors in enhancing blood sa…Individual donor nucleic acid testing for blood safety against HIV-1 and hepatitis B and C viruses in a tertiary care hospital. (2013)Individual donor nucleic acid…Need for Nucleic Acid Testing in Countries with High Prevalence of Transfusion-Transmitted Infections (2012)Need for Nucleic Acid Testing…International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009 (2011)International survey on NAT t…Nucleic acid testing (NAT) in high prevalence–low resource settings (2010)Nucleic acid testing (NAT) in…Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 2003 (2005)Estimates of the frequency of…Blood safety and nucleic acid testing in Europe (2005)Blood safety and nucleic acid…A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)A new strategy for estimating…Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)Detection of HIV-1 and HCV In…The German experience with NAT (2002)The German experience with NATFeasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting (1999)Comparative analysis of triplex nucleic acid test assays in United States blood donors (2013)Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety? (2013)History and Future of Nucleic Acid Amplification Technology Blood Donor Testing (2019)NAT of the United States and Canadian blood supply (2000)Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases (2000)Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Residual risk of transmission of human immunodeficiency virus and hepatitis C virus infections by blood transfusion in northern Brazil (2017)Assessment of Blood Donation and Transfusion in Eastern Uganda: A Mixed-Methods Study (2019)High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan (2003)Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States (2004)Nucleic acid amplification testing in Indian blood banks: A review with perspectives (2017)Seroprevalence & changing trends of transfusion-transmitted infections amongst blood donors in a Regional Blood Transfusion Centre in north India (2017)Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource‐poor settings (2005)Impact of individual‐donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa (2009)Trends in prevalence, incidence, and residual risk of major transfusion‐transmissible viral infections in United Arab Emirates blood donors: impact of individual‐donation nucleic acid testing, 2004 through 2009 (2012)The Risk of Transfusion-Transmitted Viral Infections (1996)Transfusion-transmitted infections (2007)Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing (2010)Prevention of transfusion-transmitted infections (2019)Current and Emerging Infectious Risks of Blood Transfusions (2003)Residual risk of transfusion‐transmitted viral infections in Shenzhen, China, 2001 through 2004 (2007)Views and experiences of men who have sex with men on the ban on blood donation: a cross sectional survey with qualitative interviews (2011)Prevalence and Trend of Major Transfusion-Transmissible Infections among Blood Donors in Western China, 2005 through 2010 (2014)Blood donor screening with cobas s 201/cobas TaqScreen MPX under routine conditions at German Red Cross institutes (2009)Evaluation of two, commercial, multi‐dye, nucleic acid amplification technology tests, for HBV/HCV/HIV‐1/HIV‐2 and B19V/HAV, for screening blood and plasma for further manufacture (2012)Three-Year Experience in NAT Screening of Blood Donors for Transfusion Transmitted Viruses in Croatia (2017)Surveillance of Transfusion-Transmissible Infections (2011)Screening Donated Blood for Transfusion Transmitted Infections by Serology along with NAT and Response Rate to Notification of Reactive Results: An Indian Experience (2014)
this work references cited by second hop

References

  • 2004Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing535 cited
  • 2005A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors426 cited
  • 2011International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009191 cited
  • 2005Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 200397 cited
  • 2005Blood safety and nucleic acid testing in Europe60 cited
  • 2012Need for Nucleic Acid Testing in Countries with High Prevalence of Transfusion-Transmitted Infections48 cited
  • 2013Individual donor nucleic acid testing for blood safety against HIV-1 and hepatitis B and C viruses in a tertiary care hospital.48 cited
  • 2010Nucleic acid testing (NAT) in high prevalence–low resource settings47 cited
  • 2002The German experience with NAT40 cited
  • 2015Automated nucleic acid amplification testing in blood banks: An additional layer of blood safety36 cited
  • 2015Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety35 cited
  • 2014Half a decade of mini-pool nucleic acid testing: Cost-effective way for improving blood safety in India25 cited
  • 2015Voluntary blood donation in India: Achievements, expectations and challenges

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

23 cited
  • 2014Factors in enhancing blood safety by nucleic acid technology testing for human immunodeficiency virus, hepatitis C virus and hepatitis B virus17 cited
  • Cited by

    No citing works inside the corpus for this window.